PRF Technologies Ltd. PRFX 深 滬
等待開盤 06-09 09:30:00 美东时间
1.46
-0.130
-8.18%
華盛通- 最 高1.58
- 今 開1.53
- 成交量 113.47万股
- 最 低 1.38
- 昨 收 1.59
- 總市值 126.84万
- 52周最高 17.95
- 市盈率 靜 --
- 換手率 130.61%
- 52周最低 1.28
- 委 比 -84.10%
- 總股本 86.88万
- 歷史最高 9420.00
- 量 比 1.04
- 振 幅 12.58%
- 歷史最低 1.38
- 每 手 1
- 風險率 2.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is PRF Tech Stock Falling On Monday?
PRF Technologies (NASDAQ:PRFX) stock falls sharply Monday morning. Read why analysts see this as a market correction after Friday's 186% surge.
06-01 21:51
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers PRF Technologies (NASDAQ:PRFX) stock rose 231.0% to $4.54 during Frida...
05-30 01:06
美股夜盘 | PRF Technologies Ltd.涨235.77%，Nexera Technologies Ltd涨65.52%
Creative Global Technology Holdings Limited Class A涨-27.76%；斯普林特涨-16.87%；Intercont涨-11.08%
05-29 08:05
PRF Technologies Announces Results From A Preclinical Study In Domestic Pigs Directly Comparing Its Lead Product Candidate, PRF-110, To ZYNRELEF
PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. The product candidate is being developed to
05-26 20:37
EXCLUSIVE: PRF Technologies Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial
Milestone supports advancement of PRF's drop-less ocular drug-delivery platform into next-stage U.S. clinical development for post-cataract pain and inflammation
04-28 19:45
What's Going On With Pharma Company PRF Technologies On Tuesday?
PRF Technologies outlines 2025 progress, with OcuRing-K ocular drug-delivery advancement and AI solar analytics growth.
04-07 23:02
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Profusa (NASDAQ:PFSA) shares rose 148.0% to $1.88 during Monday's regul...
04-07 01:05
PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strategyDeepSolar advances from acquisition to early commercial deployment
03-27 20:05
